Pure Global

Carbamazepine - SFDA Registration ME0000002950SFDAA00022

Access comprehensive regulatory information for Carbamazepine in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000002950SFDAA00022 and manufactured by Microgenics Corporation.

This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.

Free Database
Powered by Pure Global AI
SFDA Official Data
General IVD(Others)
ME0000002950SFDAA00022
Carbamazepine
SFDA Registration: ME0000002950SFDAA00022
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Information

For the in vitro quantitative measurement of carbamazepine in human serum or plasma

Product Use

The Carbamazepine assay is used for the in vitro quantitative measurement of carbamazepine in human serum or plasma on the ARCHITECT c Systems. The measurements obtained are used in monitoring levels of carbamazepine to help ensure appropriate therapy

Device Classification
Risk Class
General IVD(Others)
Product Category
Chemicals
Product Type
IVD
Registration Information
Registration ID
ME0000002950SFDAA00022
Authorization ID
GHTF-2018-2104
Status
Active
Expire Date
November 10, 2023
Manufacturer
Manufacturer Name
Microgenics Corporation
Model Information
Model ID(s)
5P05-21
Product Accessories

[]